MAPT and Alzheimer disease: Antisplicing oligonucleotides are a method of ribonucleic acid modulation and are increasingly being used to regulate protein expression in a multitude of diseases (i.e., from Alzheimer's disease to progressive supranuclear palsy, targeting tau).